Lyons-Williams Lori 4
4 · Contineum Therapeutics, Inc. · Filed May 29, 2024
Insider Transaction Report
Form 4
Lyons-Williams Lori
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-24+29,500→ 29,500 totalExercise: $15.76Exp: 2034-05-23→ Class A Common Stock (29,500 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on April 5, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.